Quest Diagnostics Assets & Liabilities Overview 2010-2024 | DGX

Current and historical assets & liabilities overview for Quest Diagnostics (DGX) from 2010 to 2024.
Quest Diagnostics Annual Assets & Liabilities Overview
(Millions of US $)
Quest Diagnostics Quarterly Assets & Liabilities Overview
(Millions of US $)
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $15.276B $9.252B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $16.509B 9.99
DaVita (DVA) United States $11.641B 15.84
Chemed (CHE) United States $9.342B 29.00
Encompass Health (EHC) United States $8.292B 21.34
Elanco Animal Health (ELAN) United States $6.576B 14.95
Option Care Health (OPCH) United States $5.202B 19.69
RadNet (RDNT) United States $3.333B 97.34
Amedisys (AMED) United States $2.974B 21.08
LifeStance Health (LFST) United States $2.358B 0.00
Astrana Health (ASTH) United States $2.051B 25.88
U.S Physical Therapy (USPH) United States $1.562B 40.49
Addus HomeCare (ADUS) United States $1.550B 23.76
Pennant (PNTG) United States $0.622B 36.33
Aveanna Healthcare Holdings (AVAH) United States $0.444B 0.00
Atai Life Sciences (ATAI) Germany $0.313B 0.00
Daxor (DXR) United States $0.047B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.029B 0.00
ATI Physical Therapy (ATIP) United States $0.017B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Novo Integrated Sciences (NVOS) United States $0.010B 0.00
Ontrak (OTRK) United States $0.009B 0.00
IMAC Holdings (BACK) United States $0.004B 0.00